National Comprehensive Cancer Network



About NCCN

Myelodysplastic Syndromes Panel - Disclosures as of 5/23/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Eyal Attar, MD

None

Celgene Corporation;
Jannsen Pharmaceutica Products, LP

None

None

2/7/2013

John M. Bennett, MD

None

Amgen Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Onconova;
Pfizer Inc.

None

Celgene Corporation;
Johnson & Johnson

1/16/2013

Clara D. Bloomfield, MD

None

None

None

None

8/16/2012

Uma Borate, MD

GlaxoSmithKline

None

None

None

8/24/2012

Carlos M. De Castro, MD

Celgene Corporation

Alexion Pharmaceuticals, Inc.

None

None

11/1/2011

H. Joachim Deeg, MD

None

None

None

None

3/26/2012

Olga Frankfurt, MD

None

None

None

None

1/25/2012

Karin Gaensler, MD

None

None

None

None

4/10/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Guillermo Garcia-Manero, MD

Celgene Corporation;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

None

None

10/10/2012

Steven D. Gore, MD

Celgene Corporation;
Johnson & Johnson

Celgene Corporation

Celgene Corporation

None

2/1/2012

Peter L. Greenberg, MD

Amgen Inc.;
Celgene Corporation;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Onconova

Amgen Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/14/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Elizabeth Griffiths, MD

Astex Pharmaceuticals

Alexion Pharmaceuticals, Inc.;
Celgene Corporation

None

None

2/13/2013

David Head, MD

None

None

None

None

10/9/2012

Virginia M. Klimek, MD

None

None

None

None

10/11/2012

Rami Komrokji, MD

Celgene Corporation;
GlaxoSmithKline;
Ortho Biotech Products, L.P.;
Array Biopharma;
Onconova

Celgene Corporation

None

None

3/20/2012

Lori J. Maness, MD

Cyclacel, LTD

None

None

None

3/9/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Michael M. Millenson, MD, FACP

None

None

None

None

2/22/2013

Maoko Naganuma, MSc

None

None

None

None

2/28/2013

Margaret R. O'Donnell, MD

National Cancer Institute

None

None

None

8/17/2011

Paul J. Shami, MD

Eisai Inc.;
Genzyme Corporation

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/28/2013

Dorothy Shead, MS

None

None

None

None

8/3/2012

Brady L. Stein, MD, MHS

None

None

None

None

2/11/2013

Richard M. Stone, MD

Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

ARIAD Pharmaceuticals, Inc.;
Celgene Corporation;
Genzyme Corporation

None

None

10/11/2011

Peter Westervelt, MD, PhD

None

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

11/5/2012

Benton Wheeler, MD

None

None

None

None

2/15/2013

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved